skip to Main Content
upcoming events
06 April 2021

BTK inhibitors, what are the facts and what are the differences?

Objectives: CLL disease pathophysiology and BTK inhibitors efficacy data.

19 April 2021

How to treat your cardiac CLL patients?

Objectives: Pre-treatment patient assessment and Treatment selection and patient monitoring

20 April 2021

How to avoid premature treatment discontinuation?

Objectives: How to avoid premature treatment discontinuation of IMBRUVICA and other BTKi?

26 April 2021

How I treat Relapsed CLL patient?

Objectives: When to start you relapsed refractory therapy?

27 April 2021

is there a place for BMT in CLL?

Objectives: Is there a place for BMT in CLL? Real cases: Is it a CLL progression....

Webinars

Lorem Ipsum is simply dummy text of the printing…

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's…

Lorem Ipsum is simply dummy text of the printing…

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's…

Lorem Ipsum is simply dummy text of the printing…

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's…

Back To Top